The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity

Published:2017-06-03 Issue:10 Volume:19 Page:1361-1371
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Rubens Jeffrey A,Wang Sabrina Z,Price Antoinette,Weingart Melanie F,Allen Sariah J,Orr Brent A,Eberhart Charles G,Raabe Eric H

Funder

National Cancer Institute

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/10/1361/19785315/nox067.pdf

Reference46 articles.

1. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor;J Clin Oncol,2009

2. The role of SMARCB1/INI1 in development of rhabdoid tumor;Cancer Biol Ther,2009

3. Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape;J Clin Oncol,2015

4. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target;Oncotarget,2015

5. Lin28 promotes transformation and is associated with advanced human malignancies;Nat Genet,2009

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Related mechanisms, current treatments, and new perspectives in meningioma;Genes, Chromosomes and Cancer;2024-05

2. Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor;Neoplasia;2023-03

3. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson’s disease;Human Molecular Genetics;2023-02-08

4. Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors;Cell Death & Disease;2022-04-28

5. Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors;Cancer Management and Research;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3